Berman Capital Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$545K Buy
6,437
+1,876
+41% +$157K 0.09% 124
2021
Q2
$379K Buy
4,561
+622
+16% +$50.9K 0.06% 150
2021
Q1
$295K Buy
3,939
+848
+27% +$61.8K 0.06% 149
2020
Q4
$210K Sell
3,091
-1,265
-29% -$82.3K 0.05% 157
2020
Q3
$254K Buy
4,356
+1,468
+51% +$91.3K 0.07% 127
2020
Q2
$186K Buy
2,888
+210
+8% +$13.2K 0.05% 152
2020
Q1
$158K Buy
2,678
+272
+11% +$18.2K 0.05% 146
2019
Q4
$178K Buy
2,406
+160
+7% +$11.2K 0.05% 149
2019
Q3
$141K Sell
2,246
-222
-9% -$13.2K 0.04% 168
2019
Q2
$134K Buy
2,468
+1,272
+106% +$68.5K 0.04% 173
2019
Q1
$64K Sell
1,196
-575
-32% -$35.5K 0.02% 248
2018
Q4
$115K Buy
+1,771
New +$132K 0.05% 161

Other funds holding CVS

Berman Capital Advisors's CVS Position: Q3 2021 in Review

Berman Capital Advisors increased its CVS Health (CVS) stake by 41% in Q3 2021, buying an estimated $157K and bringing the position to 6,437 shares worth $545K. The position accounts for 0.09% of the portfolio, ranked #124.

Berman Capital Advisors first reported a position in CVS in Q4 2018 and has held it in 12 quarters since. 2,073 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • Berman Capital Advisors held 6,437 shares of CVS Health worth $545K as of Q3 2021.
  • Berman Capital Advisors bought 1,876 CVS Health shares in Q3 2021, an estimated $157K.
  • CVS Health made up 0.09% of Berman Capital Advisors's portfolio in Q3 2021, its #124 holding.
  • Berman Capital Advisors first reported a position in CVS Health in Q4 2018 and has held it in 12 quarters since.
  • 2,073 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.